Articles tagged with Cell Apoptosis
Researchers at Tokyo University of Agriculture and Technology discovered that hybrid plant cells induce programmed cell death due to protein aggregate accumulation. The study used imaging tools and a chemical chaperone to halt the process, paving the way for genetic improvement techniques to enhance crop varieties' disease resistance a...
A new compound has been developed that can prevent unwanted cell death, which could improve recovery from medical emergencies and procedures. The study's findings suggest the potential for using this 'cell death blocker' to treat conditions like cardiovascular diseases and degenerative disorders.
Parkinson's disease is a neurodegenerative disorder characterized by motor and cognitive impairments. Scientists listed ways of applying genetic engineering to study and treat the disease, including manipulating mitochondria and iron homeostasis. CRISPR technology holds promise for finding new effective treatments.
A new mechanism was discovered that induces programmed cell death in cancer cells by disrupting ion homeostasis, leading to increased reactive oxygen species and endoplasmic reticulum stress. This approach has been shown to strongly inhibit tumor growth in animal models.
Researchers found that chronic stress leads to autophagic death of adult hippocampal NSCs, causing decline in adult neurogenesis. Deleting Atg7 or SGK3 gene prevents cell death and maintains normal brain functions.
Scientists from Tokyo University of Science have discovered exactly how cell-free DNA (cfDNA) is generated, revealing its crucial role in tumor progression. The study's findings suggest that cfDNA can be targeted using DNase1L3, a novel molecule to prevent tumor metastasis and thrombosis.
In the absence of gasdermin D, caspase-1 induces apoptosis, but not pyroptosis, in macrophages. Caspase family members caspase-3 and caspase-9 are involved in this process. The study suggests that caspase-1 activates Bid, a pro-apoptotic protein, which induces cytochrome c release from mitochondria and subsequent apoptosis.
A new biomarker, TP53INP2, has been identified as a potential marker for personalized cancer treatments. This protein increases the sensitivity of cancer cells to death signals, such as TRAIL, enhancing the efficacy of chemotherapy treatments.
A new study reveals that BAX, a crucial driver of apoptosis, is activated by transient interactions with BH3-only proteins at two distant sites on the protein. This 'hit-and-run' interaction initiates the conversion of BAX into a lethal protein for cells.
Researchers at the University of Alberta found bacterial pathogens in single-celled algae can induce apoptosis, a process previously thought to occur only in large organisms. This discovery has broad implications for developing targeted antibiotics and producing biofuels from algae.
Researchers discovered that cytochrome c binds to specific membrane domains and regulates the oxidation of cardiolipin, a key player in apoptosis. This finding could lead to new drug targets for treating neurodegenerative diseases like Huntington's disease.
Researchers at the University of Bradford have identified a new biomarker that could help diagnose PAH earlier, potentially leading to better treatment options. The study reveals how a faulty gene affects cell death regulation in the blood vessels.
Researchers have discovered a role for programmed cell death in wound healing and tissue regeneration, potentially paving the way to novel regenerative medicine therapies. Adult stem cells undergo apoptosis, a type of programmed cell death, which can impact their function and fate.
Researchers used slime mold to study cell positioning in complex structures, revealing the importance of cell-cell contact and chemotaxis. The study found that individual cells can be directed to their final destination by chemical signals, such as cAMP, and cell-to-cell touch.
A study published in Developmental Cell reveals that TAK1 preserves endothelial cell survival in an inflammatory environment, suggesting its potential as a target for anti-angiogenic therapy. The researchers used a unique mouse model to show that TAK1 is essential for endothelial cell survival during inflammation and injury.
Scientists from Uppsala University have devised a simple method to rescue stressed liver cells by temporarily reducing cellular stress. This approach allows suboptimal human hepatocytes to be revived with restored functionality, increasing the availability of high-quality cells for laboratory experiments.
Iron plays a significant role in ferroptosis, a type of programmed cell death, by inducing lipid oxidation and ROS formation. A recent review by MSMU scientists reveals that glutathione peroxidase 4 reduction is the primary mechanism driving this process.
Researchers at Walter and Eliza Hall Institute identified a new component of the cell death machinery, protein VDAC2, which plays a crucial role in driving apoptosis in cancer cells. The study reveals that VDAC2 helps Bax drive apoptosis and may fine-tune cancer cells' response to anti-cancer agents.
Researchers discovered that Clostridium difficile toxins induce apoptosis in intestinal epithelial cells, providing a defense mechanism against the pathogen. The findings suggest that this cell death response protects the host from C. difficile infection, raising potential for therapeutic strategies to target gastrointestinal pathogens.
Researchers at Ruhr-Universität Bochum have gained new insights into the structure of Bax, a protein responsible for programmed cell death. The team's work, published in Cell Death and Differentiation, sheds light on the dynamics of this protein.
The study reveals that cells adjust tRNA abundance to optimize protein production in stressful situations, suggesting a new regulatory mechanism. This mechanism may play a vital role in preventing the proliferation of tumors by selectively modifying translation rates.
Scientists will investigate necroptosis, a form of programmed cell death, as a key contributor to neuronal loss in Alzheimer's. The goal is to develop therapeutics capable of blocking the necroptosis pathway and slowing or arresting cell death characteristic of the disease.
Researchers at Temple University Health System have identified four BAG3 gene variants linked to poor outcomes in African American patients with dilated cardiomyopathy. The variants facilitate programmed cell death and reduce autophagy, leading to worsening heart failure.
Researchers discovered elephants' ability to resist cancer stems from the 'zombie LIF6' gene, which kills cells poised to become cancerous. This strategy may inspire new treatments for humans by mimicking the gene's behavior or activating its existing copies.
A Stanford study discovered that apoptosis, a well-known form of cell death, spreads through perpetuating waves triggered by positive feedback loops and thresholds. This phenomenon, known as trigger waves, governs the progression of cell death in intact cells, as observed in Xenopus frog eggs.
Researchers found that cells undergo self-destruction via trigger waves that travel at a constant speed of nearly 30 micrometers per minute. This process enables large distances to be covered without losing strength or speed, challenging previous assumptions about cell death propagation.
Researchers found that roundworms create oocytes with two nuclei but destroy them through apoptosis, recycling mitochondrial material into new eggs. This process helps understand why animals target so many cells for destruction during egg formation.
Researchers at the University of Alabama at Birmingham have shown that metformin can reverse established lung fibrosis using a drug treatment targeting cell metabolism. The study used human lung fibroblasts and a mouse model of lung fibrosis, finding that metformin accelerated the resolution of well-established fibrosis.
Researchers at Texas Biomedical Research Institute have repurposed promising cancer chemotherapy drugs to target tuberculosis (TB), a deadly disease that kills four people every minute. The study found that these experimental drugs can reduce TB growth by 80% and also decrease inflammation and damage to the lungs.
A recent study reveals that dying glioblastoma cells can communicate with remaining tumor cells through extracellular vesicles, increasing aggressiveness and therapy resistance. This mechanism may provide a new target for novel cancer therapies to treat glioblastoma and potentially other cancer types.
Australian researchers have made a surprise discovery that many organs and tissues do not require apoptosis to develop normally, suggesting a link between abnormalities in cell death processes and common birth defects. The study also identified the pro-death protein BOK and its role in apoptosis.
Researchers found that healthy octogenarians have high cholesterol efflux capacity, a trait linked to reduced early signs of atherosclerosis. Additionally, two microRNAs were identified as drivers of programmed cell death in fat cells, suggesting a potential target for sustainable weight loss.
Research reveals ONC201 induces cell death through mitochondrial stress mechanisms, independent of TRAIL transcription. The compound inhibits mitochondrial respiration and reduces DNA copy number, leading to ATP depletion and cell death.
Researchers developed a quantitative pharmacodynamic assay for detecting apoptosis in fixed tumor tissue, resolving limitations of existing methods. The assay uses colocalization of γH2AX and cleaved caspase-3 markers to identify apoptotic cells with high accuracy.
Researchers discovered that HTLV-1 survives by evading immune surveillance through transient Tax expression in infected cells. This unique strategy allows the virus to maintain a population of infected leukemic cells, making it a potential target for new therapies.
A study published in PLOS Biology found that obesity is associated with a decline in taste buds due to chronic inflammation and fat accumulation. Mice fed an obesogenic diet had 25% fewer taste buds than lean mice, with increased apoptosis rates and decreased progenitor cells.
Researchers at Lomonosov Moscow State University found that removing the caveolin-binding domain from Fas-ligand protein can prevent cell death. The study suggests a new strategy for cancer treatment, as this mechanism may cause malfunctioning cells to undergo apoptosis.
A type of soil-dwelling bacterium produces a molecule that induces death in melanoma cells by targeting mitochondria. The molecule, mensacarcin, shows powerful anti-proliferative effects and can activate pathways to apoptosis, or programmed cell death.
Scientists at Albert Einstein College of Medicine have discovered a compound that directly makes cancer cells commit suicide while sparing healthy cells. The new treatment approach, BTSA1, works by triggering apoptosis in cancer cells through the BAX protein, leaving healthy cells unscathed.
Researchers from Kumamoto University developed a compound that suppresses viral budding, confining the virus within host cells and leading to cell death through apoptosis. This approach aims to eradicate latent HIV reservoirs, which are key to complete recovery from AIDS.
In a new study, researchers led by Igor E. Brodsky identified a mechanism that allows host cells to overcome the strategies used by pathogens like Yersinia bacteria to evade the immune system. By understanding this 'back-up alarm' system, scientists may be able to develop new therapies to target tumor cells and promote their demise.
Researchers discovered anastasis has two distinct stages and cells hold onto pro-survival molecules even when dying. The study's findings suggest this process may enable cancer cells to bounce back after treatment, raising questions about the long-term cellular effects of anastasis.
A recent study found that chronic cell death promotes the development of liver cancer by causing remaining cells to divide at higher rates. The researchers also identified caspase 8 as an enzyme playing a dual role in this process, involving both apoptosis and DNA repair.
Researchers identified a signaling pathway in liver cells that contributes to fatty liver disease in obesity. The study found that increased Fas content leads to liver steatosis and insulin resistance, while low BID content protects against fatty liver development.
Researchers in Germany have demonstrated that temporarily preventing hematopoietic stem cells from dying can improve HSC transplantation outcomes. By inhibiting apoptosis, HSCs can establish themselves in the bone marrow and produce healthy blood cells more effectively.
A team of researchers has decoded the complex interplay of three components in a protein network regulating programmed cell death, also known as apoptosis. Their findings suggest that interaction between Bcl-2 proteins is key to understanding this process and its link to diseases such as cancer.
Researchers developed peptide-polymer conjugates to enhance water solubility of poorly soluble anti-Alzheimer drugs. The conjugates showed inhibitory activity against Tau protein aggregation, improving cell viability and reducing apoptosis in AD models.
Researchers discovered how dying cells alert neighbors to replace them, a process called compensatory proliferation signaling (CPS). Specialized vesicles containing the CrkI protein travel to neighboring cells and cause them to create new cells.
Scientists develop a hybrid nanomaterial that releases a free-radical-generating prodrug inside tumor cells, destroying them even in oxygen-depleted conditions. The material damages cells by a ROS-type radical mechanism without the need for oxygen.
A team of researchers from Duke University found that Epstein-Barr virus manipulates B-cell reproduction and apoptosis resistance to establish latency. This unique mechanism allows the virus to persist well inside the immune system, increasing cancer risk in immunocompromised individuals.
Scientists at The Wistar Institute have identified a new function for ADAR1, which protects cells from dying due to stressors like UV radiation by regulating the response to apoptosis. This discovery sheds light on the role of ADAR1 in postnatal development and disease.
A peptide targeting senescent cells has shown evidence of improving healthspan in naturally-aged mice and mice genetically engineered to rapidly age. The approach reverses age-related loss of fur, poor kidney function, and frailty by blocking the ability of a protein implicated in senescence.
Researchers discovered molecular mechanisms of how post-translational protein modifications influence apoptosis, a process of programmed cell death. This process is crucial for maintaining tissue homeostasis and preventing diseases such as Alzheimer's and Parkinson's.
Researchers propose that naked mole-rats' exceptional longevity is due to slowing individual development, resulting in a longer youth period and decelerated aging. Similarly, human data suggests a similar slowdown in the 'Master Biological Clock', leading to increased lifespan and prolonged youth.
A study published in PNAS reveals details about Apoptosis signal-regulating kinase 1 (ASK1), a signaling protein controlling cellular behavior. The research found unexpected parts of ASK1's structure that help control its activity, shedding new light on disease processes such as Parkinson's and melanoma.
Scientists have identified microRNAs as crucial regulators of apoptosis in C. elegans embryogenesis, preserving progenitor cells and ensuring proper nervous system development. By genetically blocking specific microRNAs, researchers observed significant increases in egl-1 mRNA levels, leading to premature cell death.
Researchers develop 'release and kill' strategy to target M. tuberculosis in infected macrophages, potentially shortening TB treatment periods. The approach leverages selective apoptosis to release the bacteria from infected cells, making them susceptible to antibiotics.
Scientists at Dana-Farber Cancer Institute discovered that brain and heart tissues in young children are more prone to apoptosis, making them vulnerable to chemotherapy and radiation damage. This understanding may lead to new treatments to selectively block apoptosis in healthy tissues while maintaining sensitivity in cancer cells.
Researchers have identified protein p63 as crucial for triggering 'cell-suicide' in eye cancer cells, providing a breakthrough for metastatic uveal melanoma treatment. The discovery may lead to novel therapeutic strategies by targeting this protein in combination with other genes.
Researchers found that treating white blood cells with antibodies targeting PD-1 and PD-L1 molecules can restore their function and ability to kill bacteria. This discovery offers new hope for treating sepsis, a devastating inflammatory disease.